Skip to main content
  1. Market Insights
  2. Health
  3. Mental Health

Psychotic Disorders - Lebanon

Lebanon
  • Revenue in the Psychotic Disorders market is projected to reach US$2.77m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -13.72%, resulting in a market volume of US$1.32m by 2029.
  • In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
  • In relation to total population figures, per person revenues of US$41.82 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

In-Scope

  • Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Out-Of-Scope

  • Psychotherapy
  • Talk therapy
  • Herbal medicines
  • Digital health apps
  • Deep Brain Stimulation (DBS)
Psychotic Disorders: market data & analysis - Cover

Market Insights report

Psychotic Disorders: market data & analysis

Study Details

    Revenue

    Notes: Data was converted from local currencies using average exchange rates of the respective year.

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Patients

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Analyst Opinion

    The Psychotic Disorders market in Lebanon is experiencing significant growth and development.

    Customer preferences:
    Customers in Lebanon are increasingly seeking effective treatment options for psychotic disorders. They prioritize therapies that can alleviate symptoms and improve overall quality of life. There is a growing demand for medications that can effectively manage symptoms such as hallucinations, delusions, and disorganized thinking. Additionally, customers are also interested in therapies that minimize side effects and offer long-term benefits.

    Trends in the market:
    One of the key trends in the Psychotic Disorders market in Lebanon is the increasing adoption of atypical antipsychotic medications. These medications have gained popularity due to their ability to effectively manage symptoms with fewer side effects compared to traditional antipsychotics. The market has witnessed the introduction of several new atypical antipsychotic drugs, which have contributed to the overall growth of the market.Another trend in the market is the rising focus on personalized medicine. Healthcare providers in Lebanon are increasingly tailoring treatment plans to individual patients based on their specific needs and genetic profiles. This approach allows for more targeted and effective treatment, leading to improved outcomes for patients with psychotic disorders.

    Local special circumstances:
    Lebanon has a well-established healthcare system with a strong emphasis on mental health care. There is a network of specialized psychiatric hospitals and clinics that cater to the needs of patients with psychotic disorders. This infrastructure, combined with a growing awareness and understanding of mental health issues, has contributed to the development of the Psychotic Disorders market in the country.

    Underlying macroeconomic factors:
    Lebanon's growing economy and increasing healthcare expenditure have also played a role in the development of the Psychotic Disorders market. As the country experiences economic growth, individuals have more disposable income to spend on healthcare services, including medications for psychotic disorders. Additionally, the government has been investing in the healthcare sector, which has further supported the growth of the market.In conclusion, the Psychotic Disorders market in Lebanon is witnessing significant growth and development. Customers are seeking effective treatment options that can alleviate symptoms and improve quality of life. The market is experiencing a shift towards atypical antipsychotic medications and personalized medicine. The country's well-established healthcare system, growing awareness of mental health issues, and underlying macroeconomic factors have all contributed to the development of the market.

    Global Comparison

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

    Modeling approach / Market size:

    Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

    Additional Notes:

    The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

    Health

    Access more Market Insights on Health topics with our featured report

    Psychotic Disorders: market data & analysis - BackgroundPsychotic Disorders: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    U.S. Mental Health Issues - Statistics & Facts

    Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.